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Abstract
Introduction: The Malta Hospice Movement is a community 
palliative care team (CPCT) established in 1989. A service 
evaluation was carried out to check on reduction in physical 
distress for patients referred to the CPCT.
Method: During a period of ten weeks, all new cases referred 
for community palliative care services were included in the 
evaluation. A modified version of the Support Team Assessment 
Schedule (STAS) was used as a tool. The modifications done and 
symptoms inserted were informed by literature available on the 
frequency of symptoms in palliative care. 
The version of STAS used in this particular evaluation is 
available on http://www.kcl.ac.uk/schools/medicine/depts/
palliative/qat/stas.html. The modified STAS was delivered at 
referral, and subsequently every two weeks for a total of three 
assessments. The STAS was delivered by the same nurse. 
Results: Of the 56 newly referred patients, 34 completed 
three assessments. The most common diagnosis was GIT cancer, 
while the most common reason of referral was “support”.  There 
was a significant (1.7, p=0.039) reduction in overall mean STAS 
scores, with non-significant reductions in individual item scores. 
Males exhibited greater score reductions than females. The 
symptom prevalence of patients remained unaltered throughout 
the evaluation.
Conclusions: There was reduction in physical distress 
for patients referred to the CPCT due to a variety of factors 
interacting at community level. However, symptom prevalence 
was unaltered. The results may be explained by the setting of 
care (community), lack of awareness of the present service to 
other stakeholders including family doctors and problems with 
access to relevant medications and out-of-hours cover.  
Introduction
Palliative care can be defined as the holistic management 
of the patient and family/carers with the aim of improving the 
quality of life in patients with non-curable disorders.1 According 
to the National Institute of Clinical Excellence there is a “…
relative paucity of research evidence on many key topics” 2 in 
palliative care, which is due to the difficulty in carrying out 
research in this area of medicine.3-6 An alternative tool that 
can be used to strengthen the evidence base of palliative care 
is service evaluation. Service evaluation looks at whether an 
existent service is justified and effective in reaching its stated 
objectives.7
A recent systematic review8 showed a small positive effect 
when it came to hospital based palliative care teams. The number 
of studies addressing only community care is far less. However, it 
has been shown that community palliative care teams manage to 
decrease scores in many of the symptoms reported by patients9, 
whereas another study demonstrated that symptoms in the 
final week of life were relatively well controlled by community 
based teams.10
The community palliative service under evaluation was 
established in 1989. It is the only community palliative care 
service available in the Maltese islands, with a population of 
about 410,000. Up to the time of the present evaluation, this was 
the first instance that such an exercise was being performed.
Methodology
Selection of a tool
For this particular service evaluation, it was decided to use 
an evaluation tool instead of a structured interview with patients. 
A specific detailed symptom enquiry using a predefined list of 
symptoms in the tool is more suited for comparative analysis 
than a semi-structured interview where the patients volunteer 
symptoms themselves.11 
A list of desirable characteristics used frequently in assessing 
various other audit tools was drafted to facilitate the choice of the 
evaluation tool.12,13 Subsequently a literature search was carried 
out. The databases employed were Medline, Embase and Cinahl 
and the search was restricted to the period 1990-2008. The key 
words used included “palliative care”; “evaluation” and “audit.” 
Table 1 summarises the results of the search, and as can be seen, 
when compared with other commonly used assessment tools, 
the Support Team Assessment Schedule (STAS) was the only 
tool that met all of the set criteria.
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Support Team Assessment Schedule (STAS)
STAS was purposely developed for teams to evaluate their 
care services. This tool has been extensively validated, used 
in different settings and has even been translated into several 
languages.14-17 The STAS consists of a questionnaire using a 
0-4 Likert scale on various themes pertaining to palliative care 
including pain, spirituality, psychological and financial issues. 
In total there are 17 questions. A modified version of STAS has 
been used for this evaluation, which is available at http://www.
kcl.ac.uk/schools/medicine/depts/palliative/qat/stas.html. It is 
not uncommon to modify STAS.18 The focus of this evaluation is 
the management of physical distress. STAS contains a number 
of items which are not strictly related to physical distress. 
Hence some questions e.g. financial issues were excluded. 
Items concerning spirituality, though admittedly relevant in 
physical distress, were also omitted since it was felt that the 
majority of the Maltese population is not appreciative of the 
distinction between spirituality and religiosity. This has also 
been found to be an issue in other staunchly Catholic countries 
such as Italy.19
Since the focus of this project is the reduction in physical 
distress of patients, it was felt that the second question 
was neither specific nor sufficiently detailed. STAS divides 
symptomatology into two broad categories, namely pain and 
other symptoms. With respect to the latter, different symptoms 
are grouped under this single question and some of them are 
as diverse as nausea and dyspnoea. Hence the second question 
was substituted and expanded into questions on individual 
symptoms as suggested in McKee’s expansion of the core STAS 
audit tool.20 The list of symptoms has been adapted from The 
Palliative Care Assessment (PACA) tool21 and includes:
• Dyspnoea
• Nausea
• Anorexia
• Oral discomfort 
• Constipation.
These symptoms were chosen since they are particularly 
prevalent in the palliative care scenario.22,23
Adopted procedure
A protocol was set-up to establish how this evaluation should 
proceed. Every effort was made to encourage ownership, by 
the staff, of this evaluation process.24,25 In addition, the SPREE 
framework (small, plan, regular, exchange, enjoy) was kept in 
mind while carrying out the evaluation.26 Consequently, the 
following measures were adopted:
• Adequate notice was given to all staff prior to the 
commencement of the actual process, following approval 
from the management.
• A discussion group was carried out. Feedback was sought 
via a SWOT (strengths, weaknesses, opportunities and 
threats) analysis. 
• Each nurse carried out a pilot assessment a few weeks 
before the actual evaluation, both as practice as well as to 
allow enough time to iron out teething problems. This also 
gave the author some insight on the scores involved. 
Since the nurse acts as the key worker, carrying out the 
primary assessment of the patient on referral and presenting 
the case to the rest of the team, it was felt that the nurses were in 
the best position to deliver the STAS. STAS was delivered at the 
primary assessment, and following that, every two weeks for the 
first month after referral. It is important to note, that the same 
nurse delivered each STAS. This was encouraged in order to 
decrease inter-observer bias and increase credibility of findings. 
The two week period was chosen after reviewing the literature 
available.12,18 Given the community setting, where coordinating 
interventions is much more difficult and time-consuming when 
compared to an in-patient setting, the two week interval was 
deemed more appropriate than a shorter one.
Ethical approval was obtained from the University of Malta 
Research Ethics Committee. Data was analysed using SPSS 
version 15.0, while data was compiled using Excel.
Results
During the service evaluation, 56 patients were referred as 
new cases. Thirty one (55.4%) patients were male, whereas 25 
(44.6%) were females. The mean age was 69.2 years.
Table 1: Comparison of Different Evaluation Tools
Tool Desirable Characteristics 
 Reliable Quick & easy Used in the Can be completed Holistic assessment
 & Valid to complete community by Staff of physical distress
EFAT + + - + -
SDS + + - + -
ESAS + - - - -
CAMPAS - - + + +
POS + + + + -
Rott. Checklist + - - + -
STAS + + + + +
Key: EFAT – Edmonton Functional Assessment Tool; SDS – Symptom Distress Scale; ESAS – Edmonton Symptom Assessment Scale; CAMPAS – Cambridge 
Palliative Audit Schedule; POS – Palliative Outcome Scale; Rott. Checklist – Rotterdam Checklist; STAS – Support Team Assessment Schedule
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Table 2: Frequency of diagnosis
Diagnosis Frequency Percent
Gastrointestinal Tract (GIT) 20 35.7
Respiratory and Intrathoracic  8 14.3
Breast 7 13.0
Male Genital Organ 4 7.0
Brain and Spinal Cord 4 7.0
Lymphoid and Haemopoietic Tissue 4 7.0
Others 4 7.0
Female Genital Organs 3 5.4
Lip, Oral cavity and Pharynx 1 1.8
Motor Neurone Disease 1 1.8
Total 56 100
Table 3: Reason for referral
Reason for referral Frequency Percent
Support 25 44.6
Palliative Care 3 5.4
Equipment 8 14.3
Equipment & Support 
  (when quoted together; 
 not the sum of 1 & 3) 12 21.4
Palliative Care & equipment 
 (when quoted together; 
 not the sum of 2 & 3) 1 1.8
Uncontrolled symptoms 3 5.4
Other 3 5.4
Total 55 98.2
Absent/not written down 1 1.8
Grand total  56 100
Figure 1 illustrates the flow of patients during the service 
evaluation and the total number of patients completing STAS 
measurements. A total of 139 assessments were completed.  Five 
assessments were refused since the patients declared that they 
were feeling well and did not need review.
Table 2 outlines the range of diagnoses for all 56 patients 
involved in the service evaluation. The most common diagnosis 
for the referred patients was gastrointestinal (GIT) cancers 
(35.71%), followed by respiratory and Intrathoracic cancers 
(14.29%). Breast cancer was third most common with 12.50%. 
Figure 2: Prevalence of symptoms along the assessments for the 34 patients who completed all three assessments
Figure 1: Flow of patients during the evaluation
Patients who deceased = 6
Patients refusing assessment = 1
Patients who deceased = 8
Patients refusing assessment = 4
Third STAS Assessment (n=34)
First STAS Assessment (n=56)
Second STAS Assessment (n=49)
Table 3 lists the reasons why patients were referred to 
community palliative services. The most commonly cited reason 
was “support.”  This is an umbrella term, which was used in the 
referrals to loosely include “home support”, “support to family”, 
“emotional support” and “patient support.” Another commonly 
cited reason was provision of various aids and equipment to help 
the management of patients in the community. 
Analysis of STAS scores
The STAS scores were analysed according to the following 
scheme:
•	 Total	mean	scores (Table 4)
 Two-tailed parametric t-tests were used to compare score 
means. There was a significant reduction from the first 
STAS mean to the third STAS mean (1.7, p=0.039).
•	 Symptom	Prevalence	and	Individual	Item	scores	
 (Figure 2 & 3)
 A symptom was regarded as being present if the STAS score 
was greater than zero. The most prevalent symptom at 
primary assessment was pain. The presence of symptoms 
was more or less constant, in contrast to the individual 
item scores (Figure 4), where there is a clear drop in scores 
between the first and last assessment in most cases, though 
this failed to reach statistical significance.
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•	 Variations	of	STAS	scores	related	to	gender	(Figure	4)
 Score reduction for males was statistically significant (3.27, 
p=0.029), whereas females showed a smaller reduction 
which was non-significant (0.47, p=0.597).  
Discussion
The following discussion is divided into four sections. The 
first section deals with the characteristics of the population 
studied, the second section addresses symptom prevalence, 
the third section focuses on STAS scores, while the final section 
considers the strengths and limitations of the study.
Demographic characteristics
The total number of patients referred during this period 
was 56, but only 34 patients managed to complete three STAS 
assessments. This high attrition rate is symbolic of palliative 
care research.27,28 Unfortunately, due to time pressure and the 
limited human resources available, the study could only be 
carried out for two months, thereby limiting the number of 
patients involved.
The demographic profile, with respect to sex and age, of 
the population referred to community palliative care services, 
is similar to that of other studies.12,29 The spectrum of diagnoses 
of the population under study is similar to other studies30 with 
GIT cancer (35.71%) being the most common diagnosis. It 
must be stated that cancers with the highest prevalence are 
lung and breast cancers. GIT cancer is an umbrella term which 
encompasses different cancers and when added together surpass 
lung or breast cancer.
Symptom prevalence
In this evaluation, the symptom load, or prevalence of 
symptoms seems to be consistent with other studies.23 The 
frequency of symptoms reported depends on four factors.28 
These four factors will be used for further analysis.
Setting of care: Different levels of treatment may be 
provided to control symptoms according to care setting, 
resulting in differences in symptom prevalence between care 
settings.23 It can be argued, that the caring environment, 
continuous supervision and also support provided by an in-
patient unit as opposed to the situation in the community, 
will almost certainly influence the frequency and distribution 
of symptoms. In addition, the setting of care may influence 
results since it facilitates increasing frequency of delivery of 
the evaluation tool. 
Figure 3: Individual Item Scores along the assessments. Comparison valid only for 
the 34 patients completing all three STAS scores
Table 4: Reduction in mean STAS scores
Compared STAS  Number of Means Difference 95% Confidence P Value
Assessments Patients  in Means Interval   
First – Second 49 9.69 – 9.18 0.51 -1.05 – 2.07 0.514
Second – Third 34 8.71 – 8.24 0.47 -1.15 – 2.10 0.558
First – Third 34 9.94 – 8.24 1.70 0.89 – 3.32 0.039
Figure 4: Reduction in STAS scores according to sex
16 Malta Medical Journal    Volume 21   Issue 04   December 2009
Assessment tools: It is important to point out that 
symptoms such as “weakness” and “weight loss” are not listed 
in the STAS questionnaire, despite being amongst the most 
common symptoms in a community setting.23 These symptoms 
are particularly difficult to manage, and their absence in the 
assessment tool may well have influenced the STAS scores.
Study design: The present study was a service evaluation 
of one particular community palliative care service. A different 
approach might have yielded different results. Study design can 
be seen to influence results in two major ways – either via the 
tool used, or via the number of patients or centres involved. For 
example, if the Edmonton Symptom Assessment Tool (ESAT) 
were used, the evaluation would have focused on symptoms 
scores, eliminating confounding factors such as the “non-
physical” items present in STAS. 
Different cancer types: It is a well known fact that morbidity 
in cancer patients depends also on the cancer type.31,32 However, 
the profile of diagnoses in this study is comparable to other 
cohorts, and as such not a significant issue in the interpretation 
of results. Symptom prevalence is also a result of the disease 
process itself. Interventions provided to reduce physical distress 
are not uniquely responsible for increase/decrease in symptom 
severity/reduction.
STAS scores
The successive mean STAS scores for the patients completing 
all three assessments clearly show a significant, albeit small 
reduction in scores, in line with other studies.8,9  The percentage 
of patients reporting symptoms remained rather stable. In the 
literature, there are contrasting views on symptom prevalence 
in palliative care, with some studies concluding that symptom 
frequency increases towards death33, while others report a 
variation in progression.28,30 Most of these studies followed 
patients till their demise, and hence comparison with this 
evaluation is not appropriate.
Thus patient referred to the CPCT under review had a 
stable symptom load but a reduction overall STAS scores. 
This paradoxical situation can be due to any of the four factors 
outlined in the previous section. The setting of care, in particular, 
probably plays an important role, since treatment options 
are more restricted. Indeed “symptoms such as dyspnoea or 
massive bleeding are more easily managed in the hospital.”33 
In addition, the organization of the local health system does 
not allow sufficient access to secondary care resources from the 
community in order to achieve optimum symptom control.
The importance of the assessment tool (STAS) in interpreting 
results has been highlighted previously. With regards to 
the paradox observed between STAS score reductions and 
unrelenting symptom prevalence, one could argue that the 
absence of asthenia and weight loss from STAS may have 
artificially inflated the reductions in overall STAS scores, 
given the well known difficulty in effectively treating these 
two symptoms. Another possible explanation for the above 
mentioned paradox could be the contribution of the non-
physical items to the overall STAS score. Nearly all non-physical 
items showed substantial individual item score reductions, 
particularly the patient insight item. These reductions contribute 
to the overall STAS reductions, but are foreign to the actual 
reduction in the physical distress items.   
A final possible explanation lays in the misconceptions which 
GPs and hospital based specialists may have of the community 
palliative care team members. As seen by outsiders, there may 
be a lack of definition of what the team members, including 
nurses and doctors do, which may contribute to underutilisation 
or wrong utilisation of our resources. This situation has been 
clearly documented in the literature.34, 35
An interesting feature of the individual item scores is the 
persistently higher scores for patient insight when compared to 
family insight. The reason for such phenomenon can be seen in 
the Mediterranean culture of “covert” working, in that the family 
could exert pressure on professionals to withhold information 
regarding diagnosis or prognosis from the patient in the belief 
that such information can be harmful to the patient.19, 36
Male patients were observed to have greater score reductions 
overall when compared to female patients. This dichotomy is 
interesting and possibly supported by the literature. In fact, 
females exhibit higher levels of fatigue than male patients, while 
male patients tend to do better with control of gastrointestinal 
symptoms.37,38 A possible explanation for such difference 
in response can be found by referring to the grief models of 
Stroebe and Schut.39 Males tend to adopt “restoration focused” 
mechanisms as opposed to females who adopt a “loss focused” 
mechanism. One could postulate that this model can be applied 
in the dimension of symptom control, and would effectively 
explain the above observations.
Strengths and limitations
A particular strength of this study lies in the fact that all new 
cases referred during a particular point in time were included, 
thus eliminating bias. A widely used, validated and reliable 
assessment tool (STAS) was used for the study, with some 
modifications. Paradoxically, this same tool can also be seen to 
be a possible confounding source of the results. STAS does not 
list “weight loss” or “fatigue.” These symptoms are very difficult 
to address, and their omission from the questionnaire could have 
lead to an artificial accentuation of score reduction. In addition, 
though the “non-physical” items are important, the fact that 
symptom prevalence did not decrease may imply that after all, 
overall STAS reductions were statistically significant due to the 
contribution of these “non-physical” item scores.  
There is a variety of factors interacting at community level. 
These include the actual members of the CPCT, GPs, hospital 
doctors and the patients’ carers. Trying to dissect which force 
is responsible for the results is quite difficult. Certainly the 
CPCT contributes significantly to this equation. One can thus 
conclude that the sum of these factors actually reduces the 
physical distress of patients.
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Despite including all new cases, the evaluation process 
took place during a particular period of the year, and this could 
have influenced the conclusions of the study. Unfortunately the 
robustness of the results is undermined by the small number of 
patients enrolled and the high attrition, which nearly reduced 
the patient pool by a third. In the future, this could be addressed 
by prolonging the period over which new patients are accrued 
to the study, which would increase the total patient pool as well 
as provide larger duration of follow-up.
Conclusion
In summary, patients referred to the CPCT under evaluation 
had reduction in STAS scores, non-significant reduction in 
individual item scores and a stable symptom load. Hence there 
is reduction of the physical distress of patients, but there is 
room for improvement.
This was the first ever evaluation of a community palliative 
care service locally. The study should hopefully help to establish 
this specialty at a local level and contribute locally to the 
propagation of audit and evaluation philosophy, even outside 
palliative care. Future (and possibly larger) evaluations are 
planned to assess whether changes triggered by this study will 
effectively improve the care of patients.
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